BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 18237806)

  • 1. Prediction of prognosis using standardized uptake value of 2-[(18)F] fluoro-2-deoxy-d-glucose positron emission tomography for nasopharyngeal carcinomas.
    Lee SW; Nam SY; Im KC; Kim JS; Choi EK; Ahn SD; Park SH; Kim SY; Lee BJ; Kim JH
    Radiother Oncol; 2008 May; 87(2):211-6. PubMed ID: 18237806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of 18F-FDG PET/CT before and after radiotherapy for locally advanced nasopharyngeal carcinoma.
    Xie P; Yue JB; Fu Z; Feng R; Yu JM
    Ann Oncol; 2010 May; 21(5):1078-82. PubMed ID: 19914960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of pretreatment FDG-PET SUV parameters in head-and-neck cancer: tumor SUVmean has superior prognostic value.
    Higgins KA; Hoang JK; Roach MC; Chino J; Yoo DS; Turkington TG; Brizel DM
    Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):548-53. PubMed ID: 21277108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of 18F-FDG PET/CT as a predictive biomarker of outcome in patients with head-and-neck non-squamous cell carcinoma.
    Imsande HM; Davison JM; Truong MT; Devaiah AK; Mercier GA; Ozonoff AJ; Subramaniam RM
    AJR Am J Roentgenol; 2011 Oct; 197(4):976-80. PubMed ID: 21940588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of outcome in head-and-neck cancer patients using the standardized uptake value of 2-[18F]fluoro-2-deoxy-D-glucose.
    Allal AS; Slosman DO; Kebdani T; Allaoua M; Lehmann W; Dulguerov P
    Int J Radiat Oncol Biol Phys; 2004 Aug; 59(5):1295-300. PubMed ID: 15275712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High 2-[18F]fluoro-2-deoxy-d-glucose (18FDG) uptake measured by positron emission tomography is associated with reduced overall survival in patients with oral squamous cell carcinoma.
    Hofele C; Freier K; Thiele OC; Haberkorn U; Buchmann I
    Oral Oncol; 2009 Nov; 45(11):963-7. PubMed ID: 19665923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 18F-FDG PET and combined 18F-FDG-contrast CT parameters as predictors of tumor control for hepatocellular carcinoma after stereotactic ablative radiotherapy.
    Huang WY; Kao CH; Huang WS; Chen CM; Chang LP; Lee MS; Chao HL; Chiu CH; Lo CH; Jen YM
    J Nucl Med; 2013 Oct; 54(10):1710-6. PubMed ID: 23970365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Standardized uptake value of 2-[(18)F] fluoro-2-deoxy-D-glucose in predicting outcome in head and neck carcinomas treated by radiotherapy with or without chemotherapy.
    Allal AS; Dulguerov P; Allaoua M; Haenggeli CA; El-Ghazi el A; Lehmann W; Slosman DO
    J Clin Oncol; 2002 Mar; 20(5):1398-404. PubMed ID: 11870185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [18F]FLT-PET and [18F]FDG-PET in the evaluation of radiotherapy for laryngeal cancer.
    Been LB; Hoekstra HJ; Suurmeijer AJ; Jager PL; van der Laan BF; Elsinga PH
    Oral Oncol; 2009 Dec; 45(12):e211-5. PubMed ID: 19692292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical utility of 18F-FDG PET parameters in patients with advanced nasopharyngeal carcinoma: predictive role for different survival endpoints and impact on prognostic stratification.
    Chan SC; Chang JT; Lin CY; Ng SH; Wang HM; Liao CT; Chang CJ; Lin SY; Yen TC
    Nucl Med Commun; 2011 Nov; 32(11):989-96. PubMed ID: 21862944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of pretreatment FDG-PET in nasopharyngeal carcinoma treated with intensity-modulated radiotherapy.
    Liu WS; Wu MF; Tseng HC; Liu JT; Weng JH; Li YC; Lee JK
    Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):561-6. PubMed ID: 21300483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The standardized uptake value for F-18 fluorodeoxyglucose is a sensitive predictive biomarker for cervical cancer treatment response and survival.
    Kidd EA; Siegel BA; Dehdashti F; Grigsby PW
    Cancer; 2007 Oct; 110(8):1738-44. PubMed ID: 17786947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Limited Prognostic Value of SUV max Measured by F-18 FDG PET/CT in Newly Diagnosed Small Cell Lung Cancer Patients.
    Kim SJ; Chang S
    Oncol Res Treat; 2015; 38(11):577-85. PubMed ID: 26599271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 18F-FDG-PET for evaluation of the response to concurrent chemoradiation therapy with intensity-modulated radiation technique for Stage T4 nasopharyngeal carcinoma.
    Yen TC; Lin CY; Wang HM; Huang SF; Liao CT; Kang CJ; Ng SH; Chan SC; Fan KH; Chen IH; Lin WJ; Cheng AJ; Chang JT
    Int J Radiat Oncol Biol Phys; 2006 Aug; 65(5):1307-14. PubMed ID: 16863922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Can 18F-FDG-PET response during radiotherapy be used as a predictive factor for the outcome of head and neck cancer patients?
    Farrag A; Ceulemans G; Voordeckers M; Everaert H; Storme G
    Nucl Med Commun; 2010 Jun; 31(6):495-501. PubMed ID: 20351599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prognostic value of (18)F-fluorodeoxyglucose uptake in patients with non-small cell lung cancer treated by concurrent chemoradiotherapy].
    Zhang HQ; Yu JM; Meng X; Yue JB; Feng R; Ma L
    Zhonghua Zhong Liu Za Zhi; 2010 Aug; 32(8):603-6. PubMed ID: 21122413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preoperative F-18 fluorodeoxyglucose-positron emission tomography maximal standardized uptake value predicts survival after lung cancer resection.
    Downey RJ; Akhurst T; Gonen M; Vincent A; Bains MS; Larson S; Rusch V
    J Clin Oncol; 2004 Aug; 22(16):3255-60. PubMed ID: 15310769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pretreatment [
    Gihbid A; Cherkaoui Salhi G; El Alami I; Belgadir H; Tawfiq N; Bendahou K; El Mzibri M; Cadi R; El Benna N; Guensi A; Khyatti M
    Ann Nucl Med; 2022 Oct; 36(10):876-886. PubMed ID: 35836088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anal cancer maximum F-18 fluorodeoxyglucose uptake on positron emission tomography is correlated with prognosis.
    Kidd EA; Dehdashti F; Siegel BA; Grigsby PW
    Radiother Oncol; 2010 Jun; 95(3):288-91. PubMed ID: 20231040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical significance of the post-radiotherapy
    Jeong Y; Jung IH; Kim JS; Chang SK; Lee SW
    Br J Radiol; 2019 Oct; 92(1102):20180045. PubMed ID: 30102562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.